Results 171 to 180 of about 2,984 (199)

Pharmacokinetics and Safety of Letermovir Coadministered With Cyclosporine A or Tacrolimus in Healthy Subjects

Clinical Pharmacology in Drug Development, 2018
Dirk Kropeit
exaly  

Letermovir/valganciclovir

Reactions Weekly, 2021
openaire   +1 more source

Use of Letermovir as Salvage Therapy for Drug-Resistant Cytomegalovirus Retinitis

Antimicrobial Agents and Chemotherapy, 2019
Nicholas A Turner, Dilraj S Grewal, Arthur W Baker   +2 more
exaly  

Preemptive treatment of Cytomegalovirus infection in kidney transplant recipients with letermovir: results of a Phase 2a study

Transplant International, 2014
Michael Duerr, Dietrich W Beelen, Detlef Michel   +2 more
exaly  

Ganciclovir/letermovir

Reactions Weekly, 2023
openaire   +1 more source

A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation

Clinical Infectious Diseases, 2020
Per Ljungman, Michael Schmitt, Francisco M Marty   +2 more
exaly  

Ciclosporin/letermovir

Reactions Weekly, 2022
openaire   +1 more source

Pharmacokinetic Drug‐Drug Interactions Between Letermovir and the Immunosuppressants Cyclosporine, Tacrolimus, Sirolimus, and Mycophenolate Mofetil

Journal of Clinical Pharmacology, 2019
Carolyn R Cho, Walter K Kraft
exaly  

Pharmacokinetics and Tolerability of Letermovir Coadministered With Azole Antifungals (Posaconazole or Voriconazole) in Healthy Subjects

Journal of Clinical Pharmacology, 2018
Carolyn R Cho
exaly  

Pharmacokinetics and safety of the anti‐human cytomegalovirus drug letermovir in subjects with hepatic impairment

British Journal of Clinical Pharmacology, 2017
Dirk Kropeit
exaly